Dr Reddys Laboratories Uk Betapharm Arzneimittel competitive analysis

Explore patent oppositions filed by Dr Reddys Laboratories Uk Betapharm Arzneimittel against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 18, 2025
Use Of DaptomycinCUBIST PHARMACEUTICALSMay 24, 2017
Methods For Concomitant Treatment Of Theophylline And FebuxostatTAKEDA PHARMACEUTICALS USAAug 12, 2015

Latest PTAB cases involving Dr Reddys Laboratories Uk Betapharm Arzneimittel

Discover the latest PTAB cases involving Dr Reddys Laboratories Uk Betapharm Arzneimittel, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Dr Reddys Laboratories Uk Betapharm Arzneimittel with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DR REDDYS LABORATORIES UK BETAPHARM ARZNEIMITTEL3 - - -
BOEHRINGER INGELHEIM4523289
CUBIST PHARMACEUTICALS - 11 - 13
TAKEDA PHARMACEUTICALS USA - 6 - -